Literature DB >> 19365702

Spine bone mineral density and VDR polymorphism in subjects with ulcerative colitis.

Wojciech Pluskiewicz1, Jerzy Zdrzałek, Dariusz Karasek.   

Abstract

This study established bone mineral density in subjects with ulcerative colitis with respect to disease dissemination and severity and the association between skeletal status and vitamin D receptor (VDR) polymorphism. Forty-seven patients aged 47.6 +/- 14.8 years and 47 age- and sex-matched control subjects were evaluated. Disease duration was 8.6 +/- 7.2 years. Twenty-four subjects demonstrated mild, 17 moderate, and 5 severe forms of ulcerative colitis; local (proctitis and proctosigmoiditis) changes were present in 26 and disseminated changes in 21. Bone mineral density (BMD, g/cm(2)) was assessed at the spine, and distribution of VDR polymorphism was established. In six patients (12.8%) and in two controls (4.25%), T-score for BMD was below -2.5, but mean values of BMD did not differ between all patients and controls. Patients with moderate and severe form of disease had lower BMD measurements than patients with a mild form of colitis ulcerosa (P < 0.05), and subjects with disseminated intestinal changes had lower BMD measurements than subjects with local changes (P < 0.001). Distribution of VDR polymorphism did not differ between patients and controls. Spine Z-score was dependent on VDR polymorphism (P < 0.05) in male and female patients but not in controls. We concluded that, in patients with ulcerative colitis (UC), spine bone mineral density decreases with progression and dissemination of the disease, and that VDR polymorphism is associated with spine bone mineral density. VDR genotype bb is significantly less likely to cause low BMD in male UC patients, and VDR genotype tt is more likely to cause low BMD in female patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19365702     DOI: 10.1007/s00774-009-0072-8

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  27 in total

1.  Bone mineral density in patients with inflammatory bowel disease: a population-based prospective two-year follow-up study.

Authors:  J Jahnsen; J A Falch; P Mowinckel; E Aadland
Journal:  Scand J Gastroenterol       Date:  2004-02       Impact factor: 2.423

2.  Making sense of puzzling genetic association studies: a team approach.

Authors:  Jennifer S Lee; Margaret A Tucker
Journal:  Ann Intern Med       Date:  2006-08-15       Impact factor: 25.391

3.  [The determination of BB genotype of vitamin D receptors identifies patients at risk for osteoporosis].

Authors:  S Pacini; L Nicastro; S Aterini; P Stefani; M Ruggiero
Journal:  Radiol Med       Date:  1996-11       Impact factor: 3.469

4.  Apa I polymorphism in the vitamin D receptor gene may affect the parathyroid response in Japanese with end-stage renal disease.

Authors:  K Yokoyama; T Shigematsu; T Tsukada; Y Ogura; F Takemoto; S Hara; A Yamada; Y Kawaguchi; T Hosoya
Journal:  Kidney Int       Date:  1998-02       Impact factor: 10.612

5.  Vitamin D receptor gene BsmI-polymorphism in Finnish premenopausal and postmenopausal women: its association with bone mineral density, markers of bone turnover, and intestinal calcium absorption, with adjustment for lifestyle factors.

Authors:  Marika Laaksonen; Merja Kärkkäinen; Terhi Outila; Tarja Vanninen; Carola Ray; Christel Lamberg-Allardt
Journal:  J Bone Miner Metab       Date:  2002       Impact factor: 2.626

6.  Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis.

Authors:  S Ardizzone; S Bollani; P Bettica; M Bevilacqua; P Molteni; G Bianchi Porro
Journal:  J Intern Med       Date:  2000-01       Impact factor: 8.989

7.  Prediction of bone density from vitamin D receptor alleles.

Authors:  N A Morrison; J C Qi; A Tokita; P J Kelly; L Crofts; T V Nguyen; P N Sambrook; J A Eisman
Journal:  Nature       Date:  1994-01-20       Impact factor: 49.962

8.  [Analysis of Bsm I polymorphism of the vitamin D receptor (VDR) gene in Venezuelan female patients living in the state of Zulia with osteoporosis].

Authors:  Lisbeth Borjas-Fajardo; Mariana Zambrano; Erika Fernández; Lennie Pineda; Alisandra Machín; Pilar de Romero; William Zabala; María Alejandra Sánchez; José Antonio Chacín; Wilmer Delgado
Journal:  Invest Clin       Date:  2003-12       Impact factor: 0.683

9.  Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study.

Authors:  T Card; J West; R Hubbard; R F A Logan
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

10.  Vitamin D receptor alleles and rates of bone loss: influences of years since menopause and calcium intake.

Authors:  E A Krall; P Parry; J B Lichter; B Dawson-Hughes
Journal:  J Bone Miner Res       Date:  1995-06       Impact factor: 6.741

View more
  5 in total

Review 1.  Molecular genetic studies of gene identification for osteoporosis: the 2009 update.

Authors:  Xiang-Hong Xu; Shan-Shan Dong; Yan Guo; Tie-Lin Yang; Shu-Feng Lei; Christopher J Papasian; Ming Zhao; Hong-Wen Deng
Journal:  Endocr Rev       Date:  2010-03-31       Impact factor: 19.871

2.  Vitamin D receptor gene polymorphisms and bone mass indices in post-menarchal Indian adolescent girls.

Authors:  Neha Sanwalka; Anuradha Khadilkar; Shashi Chiplonkar; Kavita Khatod; Nikhil Phadke; Vaman Khadilkar
Journal:  J Bone Miner Metab       Date:  2012-10-19       Impact factor: 2.626

Review 3.  Vitamin D and inflammatory bowel disease.

Authors:  Marco Ardesia; Guido Ferlazzo; Walter Fries
Journal:  Biomed Res Int       Date:  2015-04-27       Impact factor: 3.411

Review 4.  Bone mineral density is negatively correlated with ulcerative colitis: a systematic review and meta-analysis.

Authors:  Tianyu Zhou; Jiaqi Pan; Bin Lai; Li Cen; Wenxi Jiang; Chaohui Yu; Zhe Shen
Journal:  Clin Transl Med       Date:  2020-02-18

5.  Genetic Dissection of Trabecular Bone Structure with Mouse Intersubspecific Consomic Strains.

Authors:  Taro Kataoka; Masaru Tamura; Akiteru Maeno; Shigeharu Wakana; Toshihiko Shiroishi
Journal:  G3 (Bethesda)       Date:  2017-10-05       Impact factor: 3.154

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.